NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Intec Pharma Ltd. (NASDAQ:NTEC), Cerecor Inc. (NASDAQ:CERC), Chiasma, Inc. (NASDAQ:CHMA), Exela Technologies, Inc. (NASDAQ:XELA), PAVmed Inc. (NASDAQ:PAVM), and CUI Global, Inc. (NASDAQ:CUI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
NTEC DOWNLOAD: http://MarketSourceResearch.com/register/?so=NTEC
CERC DOWNLOAD: http://MarketSourceResearch.com/register/?so=CERC
CHMA DOWNLOAD: http://MarketSourceResearch.com/register/?so=CHMA
XELA DOWNLOAD: http://MarketSourceResearch.com/register/?so=XELA
PAVM DOWNLOAD: http://MarketSourceResearch.com/register/?so=PAVM
CUI DOWNLOAD: http://MarketSourceResearch.com/register/?so=CUI
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Intec Pharma Ltd. (NASDAQ:NTEC), Cerecor Inc. (NASDAQ:CERC), Chiasma, Inc. (NASDAQ:CHMA), Exela Technologies, Inc. (NASDAQ:XELA), PAVmed Inc. (NASDAQ:PAVM), and CUI Global, Inc. (NASDAQ:CUI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
INTEC PHARMA LTD. (NTEC) REPORT OVERVIEW
Intec Pharma's Recent Financial Performance
Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$0.92 and is expected to report on February 26th, 2020.
To read the full Intec Pharma Ltd. (NTEC) report, download it here: http://MarketSourceResearch.com/register/?so=NTEC
-----------------------------------------
CERECOR INC. (CERC) REPORT OVERVIEW
Cerecor's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Cerecor reported revenue of $4.98MM vs $2.23MM (up 123.15%) and analysts estimated basic earnings per share -$0.18 vs $0.23. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Cerecor reported revenue of $18.33MM vs $27.81MM (down 34.11%) and analysts estimated basic earnings per share -$1.20 vs $0.42. Analysts expect earnings to be released on May 10th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.72 and is expected to report on April 1st, 2019.
To read the full Cerecor Inc. (CERC) report, download it here: http://MarketSourceResearch.com/register/?so=CERC
-----------------------------------------
CHIASMA, INC. (CHMA) REPORT OVERVIEW
Chiasma's Recent Financial Performance
Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$1.18 and is expected to report on March 13th, 2020.
To read the full Chiasma, Inc. (CHMA) report, download it here: http://MarketSourceResearch.com/register/?so=CHMA
-----------------------------------------
EXELA TECHNOLOGIES, INC. (XELA) REPORT OVERVIEW
Exela Technologies' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Exela Technologies reported revenue of $399.64MM vs $386.29MM (up 3.46%) and basic earnings per share -$0.56 vs $0.52. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Exela Technologies reported revenue of $1,586.22MM vs $1,152.32MM (up 37.65%) and analysts estimated basic earnings per share -$1.09 vs -$2.08. Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.25 and is expected to report on March 16th, 2020.
To read the full Exela Technologies, Inc. (XELA) report, download it here: http://MarketSourceResearch.com/register/?so=XELA
-----------------------------------------
PAVMED INC. (PAVM) REPORT OVERVIEW
PAVmed's Recent Financial Performance
Analysts expect earnings to be released on May 20th, 2019. The report will be for the fiscal period ending March 31st, 2019.
To read the full PAVmed Inc. (PAVM) report, download it here: http://MarketSourceResearch.com/register/?so=PAVM
-----------------------------------------
CUI GLOBAL, INC. (CUI) REPORT OVERVIEW
CUI Global's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, CUI Global reported revenue of $26.95MM vs $21.14MM (up 27.52%) and analysts estimated basic earnings per share -$0.28 vs -$0.22. For the twelve months ended December 31st, 2018 vs December 31st, 2017, CUI Global reported revenue of $96.79MM vs $83.28MM (up 16.23%) and analysts estimated basic earnings per share -$0.61 vs -$0.56. Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.10. The estimated EPS forecast for the next fiscal year is $0.32 and is expected to report on March 16th, 2020.
To read the full CUI Global, Inc. (CUI) report, download it here: http://MarketSourceResearch.com/register/?so=CUI
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Jim Patterson, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.